Learn More
Medchemexpress LLC 7-(morpholin-4-yl)-2,1,3-benzoxadiazol-4-amine | 842964-18-5 | MFCD03422529 | 99.9% | 220.23 g/mol | C10H12N4O2 | 10MG

Supplier: Medchemexpress LLC HY12483210MG
δ-Secretase inhibitor 11 is a selective, orally active small-molecule inhibitor of δ-secretase used in neurodegeneration research. It is reported to be blood-brain barrier permeable and non-toxic in preclinical models, attenuating pathological cleavage of tau and amyloid precursor protein and improving synaptic function and cognition in relevant transgenic mouse models.
- Selective δ-secretase inhibition with reported IC50 0.7 μM.
- Blood-brain barrier permeable, suitable for in vivo studies.
- Reduces tau and APP cleavage in disease models.
- High reported purity (≈99.9%).
- Available as solid quantities and as 10 mM solution in DMSO.
- Useful for Alzheimer's disease mechanism and therapeutic research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.